<ѻýҕl>Radioligand Therapy Boosts Survival in Metastatic CRPCѻýҕl> PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
<ѻýҕl>With Supplements, ADT in Prostate Cancer of Little Threat to Bone Densityѻýҕl> Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
<ѻýҕl>'A Quantum Leap Forward': Potential New Standard in High-Risk RCCѻýҕl> Adjuvant immunotherapy led to 32% reduction in the risk of recurrence, positive trend in OS Jun 03, 2021
<ѻýҕl>First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancerѻýҕl> Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
<ѻýҕl>Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancerѻýҕl> No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
<ѻýҕl>Vaccination, Screening Succeeds in Cervical and Prostate Cancersѻýҕl> Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
<ѻýҕl>How Did a Patient Survive a Decade With Metastatic RCC?ѻýҕl> Surgery had beneficial role May 17, 2021
<ѻýҕl>SBRT Safe for Cancer Patients With Multiple Metastasesѻýҕl> Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<ѻýҕl>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?ѻýҕl> Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<ѻýҕl>Treatment Type a Non-Factor in Prostate Cancer Patients' Anxietyѻýҕl> Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
<ѻýҕl>Late ADT a Problem in Prostate Cancerѻýҕl> Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
<ѻýҕl>No More Men Need to Die From Transrectal Prostate Biopsiesѻýҕl> A movement toward transperineal biopsies Apr 21, 2021
<ѻýҕl>Olympic Gold Medalist Nathan Adrian's Testicular Cancerѻýҕl> The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
<ѻýҕl>Could a 'Placebo' Become the Next Big ED Treatment?ѻýҕl> Over-the-counter gel, said to spur near-instant erections, is on the cusp of approval in Europe Apr 20, 2021
<ѻýҕl>Another Player in Advanced Bladder Cancerѻýҕl> Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
<ѻýҕl>More Benefit With Taxane for Aggressive Metastatic Prostate Cancerѻýҕl> Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<ѻýҕl>Mixed Results for Immunotherapy in Metastatic Prostate Cancerѻýҕl> Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
<ѻýҕl>Overactive Bladder Drug Gains Pediatric Indicationѻýҕl> Mirabegron approved to treat kids with neurogenic detrusor overactivity Mar 26, 2021
<ѻýҕl>ENDO 2021 Roundup: Jatenzo Liver Data, Adrenal Insufficiency, and Moreѻýҕl> Other noteworthy research presented at the Endocrine Society's annual meeting Mar 25, 2021
<ѻýҕl>Choice of Erectile Dysfunction Med May Have Heart Health Implicationsѻýҕl> Large observational study of PDE-5 inhibitors vs alprostadil Mar 23, 2021
<ѻýҕl>Testicular Dysfunction May Persist Long After Anabolic Steroid Useѻýҕl> "Need to treat not just as problem of testosterone deficiency but as a body-image disorder" Mar 09, 2021
<ѻýҕl>UTIs Treated Inappropriately Everywhereѻýҕl> Both uncalled-for drugs and prolonged treatment durations, large-scale review finds Feb 26, 2021
<ѻýҕl>Vaginal Pessary Viable Alternative to Surgery for Weak Pelvic Floorѻýҕl> Majority of women continued treatment for at least 5 years Feb 24, 2021
<ѻýҕl>New Standard in High-Risk Muscle-Invasive Bladder Cancer?ѻýҕl> Adjuvant nivolumab improves DFS in all comers, PD-L1 population Feb 13, 2021
<ѻýҕl>CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancerѻýҕl> Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
<ѻýҕl>Survival Boost in Bladder Cancer With Antibody-Drug Conjugateѻýҕl> Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<ѻýҕl>Radionuclide Tx Wins in Third-Line Metastatic CRPCѻýҕl> Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
<ѻýҕl>Hit and Miss in Castration-Resistant Prostate Cancerѻýҕl> No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
<ѻýҕl>Brain Tumor Risk Upped With Synthetic Progestogenѻýҕl> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻýҕl>Whole-Pelvis Tops Prostate-Only RT in High-Risk Diseaseѻýҕl> Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
<ѻýҕl>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻýҕl> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻýҕl>Is This Really Cancer?ѻýҕl> Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>Gland Larceny: When Testicle Thefts Took Chicago by Stormѻýҕl> Male rejuvenation craze sparked kidnappings and organ harvesting Dec 09, 2020
<ѻýҕl>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Studyѻýҕl> Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<ѻýҕl>FDA OKs 'Game Changer' Radiotracer for Prostate Cancerѻýҕl> PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<ѻýҕl>Study Reassures on MS Patients' Breast, Colorectal Cancer Riskѻýҕl> But higher incidence of other cancers in Canadian data Nov 25, 2020
<ѻýҕl>Remdesivir May Keep Ebola Out of the Bedroomѻýҕl> Won't help clinical disease, but phase II trial shows it reduces virus levels in survivors' semen Nov 19, 2020